A great base for dermatological and cosmeceutical compounding requires certain qualities. For compounding pharmacies who need an anhydrous base that does the most, let us tell you about W06 and what it can do for your patients.

Mark Gonzalez, PharmD, is a Clinical Compounding Pharmacist at PCCA. He has an encouraging word for those interested in finding a career in Veterinary Compounding. The first word, he says, is to "..dream big."

Late last year, we were excited to debut PermE8™ Anhydrous Gel, a new compounding base that holds a lot of potential for compounding pharmacies and their patients, especially when it comes to pain management.

We’re excited that patients and physicians now have access to Azelastine Hydrochloride USP as an ingredient option in compounded medications. There are some commercial products available, including a combination product, but when those items don’t fit the specific needs of patients, we need to put on our thinking caps and start looking for other options for them. We’re sure that you compounders out there can come up with a few of your own as well.

By Maria Carvalho, PharmD, MRPharmS, PhD. She is the Manager of PCCA Science.

I always found compounding interesting. As a young pharmacist, working in the hospital world and later for chain pharmacy, I was always intrigued by the uniqueness of it. I was not fulfilled by hospital or chain pharmacy, though. In the chain world, I was a supervisor of 25 stores. I felt unfulfilled in that position and left to gain experience in independent pharmacy.

My father is a pharmacist. He owned a store for over 20 years, and I worked for him for 17 years. It was a family-oriented store—independent—and my parents, my brother and I worked together there. I loved filling prescriptions and learning the field as well as working with customers who became like family to us. It was the kind of job you enjoyed going to every day.

By Bryan Prescott, Pharm D-- Bryan is the Director of Management Coaching Services for PCCA’s Compounding Pharmacy Management Services.

On July 27, 2018, the Compounding Expert Committee of the United States Pharmacopeial Convention published proposed revisions to USP chapter <797> Pharmaceutical Compounding – Sterile Preparations. The proposed chapter is open to public comments until November 30, 2018, and is expected to become official on December 1, 2019.

On March 30, 2018, the Compounding Expert Committee of the United States Pharmacopeial Convention published proposed revisions to USP chapter <795> Pharmaceutical Compounding – Nonsterile Preparations. The revised chapter was open to public comments until July 31, 2018, and is expected to become official on December 1, 2019. Major revisions to the chapter include, but are not limited to, the following: